US 8114848
Immunomodulatory oligonucleotides
granted A61KA61K2039/55561A61K31/4706
Quick answer
US patent 8114848 (Immunomodulatory oligonucleotides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/55561, A61K31/4706, A61K39/39